Scribd Logo
Upload

Welcome to Scribd!

  • 8 views

    Eptinezumab

    Uploaded by

    maria.pedron

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Eptinezumab

    Uploaded by

    maria.pedron
    8 views1 page

    Original Title

    eptinezumab

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    8 views1 page

    Eptinezumab

    Uploaded by

    maria.pedron

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    of 1

    ACTIVE LEARNING TEMPLATE: Medication

    Maria Pedron
    STUDENT NAME _____________________________________
    eptinezumab (Vyepti)
    MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
    monoclonal antibodies calcitonin gene-related
    CATEGORY CLASS ______________________________________________________________________

    PURPOSE OF MEDICATION

    Expected Pharmacological Action Therapeutic Use


    migraine prevention, monoclonal antibody reduction in the frequency of migraines
    that binds to the calcitonin gene-related
    peptide receptor, w/c reduces the

    Complications Medication Administration


    hypersensitivity reactions, nasopharyngitis IV 100 mg every 3 mos, 300 mg
    every 3 mos

    Contraindications/Precautions
    CI: serious hypersensitivity
    PC: not established safety in pregnancy, safety &
    Nursing Interventions
    effectiveness not established in children
    PVC infusion bags, do not
    shake, do not infuse solutions
    that are cloudy, discolored or
    contain particulate matter,
    Interactions infuse over 30 mins through 0.2
    micron in line or add on sterile
    None reported filter. flush line w/ 20 ml of 0.9%

    Client Education
    report signs of hypersensitivity
    reactions, notify health care
    Evaluation of Medication Effectiveness
    team of all Rx, vit, herbal
    products being taken, notify
    provider if pregnancy is
    suspected, planned or if
    breastfeeding.

    ACTIVE LEARNING TEMPLATES THERAPEUTIC PROCEDURE A7

    You might also like